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ABSTRACT

Purpose:
To detect the role of optical coherence tomography in evaluation of Choriodal neovascularization in response to treatment with anti vascular endothelial growth factors (VEGF) Methods: A total of 30 eyes with treatment-naïve choriodal neovascular membrane were examined using the OCT system before treatment and after treatment with anti VEGF.
Results:
In treatment-naïve CNV, The activity of CNV had been evaluated according to structural OCT by presence of Cystoid Macular Edema (CME), Subretinal Fluid (SRF) , Fibrovascular Pigment Epithelial Detachment (FPED) and macular thickening . There is gradual decrease in CMT along the treatment course with repeated intravitreal anti-VEGF injections. 50 % of CNV patients had CME at baseline which gradually decreased with repeated anti-VEFG injections and disappeared completely after the third dose, 35 % of CNV patients had SRF at baseline which gradually decreased with repeated anti-VEFG injections and disappeared completely after the third dose, Only two patients had PED before treatment, which gradually decreased along the course of treatment by three doses of anti VEGF injections.
Conclusion:
OCT is an important modality of investigation for diagnosis of CNV and detecting activity and response with treatment with anti VEGF. This study aims to detect the role of OCT in monitoring activity of CNV along the course of treatment with Anti VEGF.
PATIENTS AND METHODS
In our retrospective analysis , patients with all types and different stages of CNV due to different etiologies ( treatment naïve ) were examined by OCT using ( Optovue, Fremont , CA, USA). All patients underwent a routine ophthalmic examination including best corrected visual acuity (BCVA) testing using Snellen charts and biomicroscopic examination. Neovascular activity was assessed by SD-OCT imaging by evidence of intra-and/or SRF .At primary presentation , the diagnosis of active CNV was made by conventional FA. Patients were recruited between August 2017 and February 2018 at the Fayoum University Hospital , Egypt .
Inclusion criteria were patients with choriodal neovascularization due to different etiologies as neovascular AMD , pathological myopia , multifocal chorioditis and trauma , treatment naïve . Patients with previous treatment by Anti VEGF or photodynamic therapy were excluded.
Procedure
Intra vitreal injection of anti VEGF (Ranibizumab) three successive doses monthly interval.
RESULTS
The present study evaluated OCT images of thirty patients with choriodal neovascularization due to different etiologies AMD, pathological myopia and multifocal chorioditis. Ten men and twenty women participated in this study with mean age of 50.6 ± 17.7 years . The mean BCVA was 0.07 ± 0.06 decimal.
Correlation between CNV type according to OCT and visual Acuity:
Five patients have CNV type 1, in which CNV lesion doesn't reach outer retina according to OCT , with median BCVA 0.17. BCVA improved gradually after injection with Anti VEGF to become 0.2, 0.2 and 0.25 after first, second and third injection respectively.
Twenty five patients have CNV type 2, in which CNV lesion reach outer retina according to OCT , with median BCVA 0.06 at base line, which improved gradually after injection with Anti VEGF to become 0.09, 0.13 and 0.14 after first, second and third injection respectively.
There is no significant differences in changes of BCVA between type one and type two CNV (Figure 1 ). BCVA improve gradually along the course of treatment with Anti VEGF.
After first injection, median BCVA was 0.09 (0.01-0.25).
After second injection, median BCVA was 0.13 (0.03-0.33).
After third injection, median BCVA was 0.15 (0.30-0.33).
4Changes of structural OCT during the course of treatment
The activity of CNV had been evaluated according to structural OCT by presence of Cystoid Macular Edema (CME), Subretinal Fluid (SRF) , Fibrovascular Pigment Epithelial Detachment (FPED) and macular thickening .
a. differences in Central macular thickness ( CMT) at different times:
There is gradual decrease in CMT along the treatment course with repeated intravitreal anti-VEGF injections. CMT is a good prognostic factor for improvement of BCVA after repeated anti-VEGF injections. The lower CMT, the better improvement in BCVA. b. ifferences in CME at different times: 50 % of CNV patients had CME at baseline which gradually decreased with repeated anti-VEFG injections and disappeared completely after the third dose (figure 2).
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Figure (2): CME changes pre-and post treatment
CME is considered a positive marker for therapeutic response to anti VEGF treatment, but a poor prognostic factor to improvement in BCVA.
c. D differences in SRF at different times:
35 % of CNV patients had SRF at baseline which gradually decreased with repeated anti-VEFG injections and disappeared completely after the third dose (Figure 3 ).
Figure (3): SRF changes pre-and post treatment
SRF is considered a positive marker for therapeutic response to anti VEGF treatment, but a poor prognostic factor to improvement in BCVA in response to anti VEGF.
d.
Differences in Pigment Epithelial Detachement (PED) at different times:
Only two patients had PED before treatment, which gradually decreased along the course of treatment by three doses of anti VEGF injections.
In our study 25 eyes show gradual regression in response to Anti VEGF along the course of injection (three times). Only five eyes show regression in activity after first injection and become stationary after second and third injection.
DISCUSSION
Choroidal neovascularization (CNV) refers to new blood vessel growth from the choroid that extends into the subretinal pigment epithelium, or the subretinal space, or a combination of both (Jian L., et.al., 2013) . It is frequently accompanied by various ophthalmic diseases in the posterior segment and is a key of pathologic change, causing severe vision loss as part of the pathogenesis of several diseases (Gehrs K., et.al., 2006) . Structural OCT has become an indispensable tool in the management of Choriodal neovascularization. It allows the clinician to assess fluid exudation from CNV as manifested by intraretinal cysts, retinal thickening, and subretinal 
